ChitogenX Inc.
CHNXF
$0.0071
-$0.0039-35.46%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -58.36% | -61.42% | -57.28% | -31.14% | -18.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -58.33% | -67.60% | -63.24% | -43.73% | -30.37% |
| Operating Income | 58.33% | 67.60% | 63.24% | 43.73% | 30.37% |
| Income Before Tax | 52.71% | 60.55% | 66.41% | 75.65% | 36.42% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 52.71% | 60.55% | 66.41% | 75.65% | 36.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 52.71% | 60.55% | 66.41% | 75.65% | 36.42% |
| EBIT | 58.33% | 67.60% | 63.24% | 43.73% | 30.37% |
| EBITDA | 58.88% | 68.16% | 63.67% | 43.89% | 30.36% |
| EPS Basic | 66.75% | 74.55% | 78.62% | 85.60% | 51.13% |
| Normalized Basic EPS | 53.48% | 68.37% | 74.64% | 83.49% | 64.52% |
| EPS Diluted | 66.75% | 74.55% | 78.62% | 85.60% | 51.13% |
| Normalized Diluted EPS | 53.48% | 68.37% | 74.64% | 83.49% | 64.52% |
| Average Basic Shares Outstanding | 28.09% | 43.16% | 58.47% | 51.28% | 46.94% |
| Average Diluted Shares Outstanding | 28.09% | 43.16% | 58.47% | 51.28% | 46.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
